脓毒症的生物标志物
Biomarkers of Sepsis.
作者信息
Agnello Luisa, Ciaccio Marcello
机构信息
Department of Biomedicine, Neurosciences and Advanced Diagnostics, Institute of Clinical Biochemistry, Clinical Molecular Medicine and Clinical Laboratory Medicine, University of Palermo, 90127 Palermo, Italy.
Department of Laboratory Medicine, University Hospital "P. Giaccone", 90127 Palermo, Italy.
出版信息
Diagnostics (Basel). 2023 Jan 25;13(3):435. doi: 10.3390/diagnostics13030435.
Abstract
Sepsis is a highly complex disease caused by a deregulated host's response to infection [...].
摘要
脓毒症是一种由宿主对感染的反应失调引起的高度复杂的疾病[……]。
相似文献
1
Biomarkers of Sepsis.脓毒症的生物标志物
Diagnostics (Basel). 2023 Jan 25;13(3):435. doi: 10.3390/diagnostics13030435.
2
[Research progress of microRNAs in sepsis-associated acute kidney injury].微小RNA在脓毒症相关性急性肾损伤中的研究进展
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2022 May;34(5):556-560. doi: 10.3760/cma.j.cn121430-20211117-01740.
3
P2X4 receptors, immunity, and sepsis.P2X4 受体、免疫与脓毒症。
Curr Opin Pharmacol. 2019 Aug;47:65-74. doi: 10.1016/j.coph.2019.02.011. Epub 2019 Mar 25.
4
The liver in sepsis: molecular mechanism of liver failure and their potential for clinical translation.脓毒症中的肝脏：肝衰竭的分子机制及其临床转化的潜力。
Mol Med. 2022 Jul 30;28(1):84. doi: 10.1186/s10020-022-00510-8.
5
The Pathogenesis of Sepsis and Potential Therapeutic Targets.脓毒症的发病机制与潜在治疗靶点
Int J Mol Sci. 2019 Oct 29;20(21):5376. doi: 10.3390/ijms20215376.
6
Metabolomics and the Microbiome as Biomarkers in Sepsis.代谢组学和微生物组作为脓毒症的生物标志物。
Crit Care Clin. 2020 Jan;36(1):105-113. doi: 10.1016/j.ccc.2019.08.008.
7
Zinc and Sepsis.锌与脓毒症。
Nutrients. 2018 Jul 27;10(8):976. doi: 10.3390/nu10080976.
8
[Clinical and etiological diagnosis of septic states].[脓毒症状态的临床与病因诊断]
Rev Prat. 1993 Jan 1;43(1):35-40.
9
The pathogenesis and diagnosis of sepsis post burn injury.烧伤后脓毒症的发病机制与诊断
Burns Trauma. 2021 Feb 4;9:tkaa047. doi: 10.1093/burnst/tkaa047. eCollection 2021 Jan.
10
Non-Coding RNA Networks as Potential Novel Biomarker and Therapeutic Target for Sepsis and Sepsis-Related Multi-Organ Failure.非编码RNA网络作为脓毒症及脓毒症相关多器官功能衰竭潜在的新型生物标志物和治疗靶点
Diagnostics (Basel). 2022 May 31;12(6):1355. doi: 10.3390/diagnostics12061355.
引用本文的文献
1
Uncovering hub genes in sepsis through bioinformatics analysis.通过生物信息学分析揭示脓毒症中的枢纽基因。
Medicine (Baltimore). 2023 Dec 1;102(48):e36237. doi: 10.1097/MD.0000000000036237.
2
Predicting the prognosis in patients with sepsis by an endoplasmic reticulum stress gene signature.通过内质网应激基因特征预测脓毒症患者的预后。
Aging (Albany NY). 2023 Nov 25;15(22):13434-13451. doi: 10.18632/aging.205252.
3
Identifying Effective Biomarkers for Accurate Pancreatic Cancer Prognosis Using Statistical Machine Learning.使用统计机器学习识别有效的生物标志物以准确预测胰腺癌预后
Diagnostics (Basel). 2023 Sep 29;13(19):3091. doi: 10.3390/diagnostics13193091.
4
The Crossroads of the Coagulation System and the Immune System: Interactions and Connections.凝血系统与免疫系统的交汇点：相互作用与关联。
Int J Mol Sci. 2023 Aug 8;24(16):12563. doi: 10.3390/ijms241612563.
本文引用的文献
1
Clusterin Plasma Concentrations Are Decreased in Sepsis and Inversely Correlated with Established Markers of Inflammation.脓毒症患者血浆中聚集素浓度降低，且与已确定的炎症标志物呈负相关。
Diagnostics (Basel). 2022 Dec 1;12(12):3010. doi: 10.3390/diagnostics12123010.
2
The Expression Levels and Concentrations of PD-1 and PD-L1 Proteins in Septic Patients: A Systematic Review.脓毒症患者中PD-1和PD-L1蛋白的表达水平及浓度：一项系统评价
Diagnostics (Basel). 2022 Aug 19;12(8):2004. doi: 10.3390/diagnostics12082004.
3
Non-Coding RNA Networks as Potential Novel Biomarker and Therapeutic Target for Sepsis and Sepsis-Related Multi-Organ Failure.非编码RNA网络作为脓毒症及脓毒症相关多器官功能衰竭潜在的新型生物标志物和治疗靶点
Diagnostics (Basel). 2022 May 31;12(6):1355. doi: 10.3390/diagnostics12061355.
4
Monocyte distribution width (MDW) as a screening tool for early detecting sepsis: a systematic review and meta-analysis.单核细胞分布宽度（MDW）作为早期检测脓毒症的筛查工具：系统评价和荟萃分析。
Clin Chem Lab Med. 2022 Feb 15;60(5):786-792. doi: 10.1515/cclm-2021-1331. Print 2022 Apr 26.
5
Weaning Failure in Critically Ill Patients Is Related to the Persistence of Sepsis Inflammation.危重症患者撤机失败与脓毒症炎症持续存在有关。
Diagnostics (Basel). 2021 Dec 31;12(1):92. doi: 10.3390/diagnostics12010092.
6
Pentraxin-3 Is a Strong Biomarker of Sepsis Severity Identification and Predictor of 90-Day Mortality in Intensive Care Units via Sepsis 3.0 Definitions.通过脓毒症3.0定义，血清淀粉样蛋白P成分是重症监护病房中脓毒症严重程度识别的有力生物标志物及90天死亡率的预测指标。
Diagnostics (Basel). 2021 Oct 15;11(10):1906. doi: 10.3390/diagnostics11101906.
7
The Value of a Complete Blood Count (CBC) for Sepsis Diagnosis and Prognosis.全血细胞计数（CBC）在脓毒症诊断和预后评估中的价值。
Diagnostics (Basel). 2021 Oct 12;11(10):1881. doi: 10.3390/diagnostics11101881.
8
Application of Peak Glucose Range and Diabetes Status in Mortality Risk Stratification in Critically Ill Patients with Sepsis.峰值血糖范围和糖尿病状态在脓毒症重症患者死亡风险分层中的应用
Diagnostics (Basel). 2021 Sep 29;11(10):1798. doi: 10.3390/diagnostics11101798.
9
Red Cell Distribution Width as a Prognostic Factor and Its Comparison with Lactate in Patients with Sepsis.红细胞分布宽度作为脓毒症患者的一个预后因素及其与乳酸的比较
Diagnostics (Basel). 2021 Aug 14;11(8):1474. doi: 10.3390/diagnostics11081474.
10
Independent Validation of Sepsis Index for Sepsis Screening in the Emergency Department.急诊科用于脓毒症筛查的脓毒症指数的独立验证
Diagnostics (Basel). 2021 Jul 19;11(7):1292. doi: 10.3390/diagnostics11071292.
Zotero 插件